|
|
|
|
| LEADER |
02769nam a2200493 4500 |
| 001 |
ocn695549660 |
| 003 |
OCoLC |
| 005 |
20170124071323.1 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
110107s2011 njua obf 001 0 eng d |
| 040 |
|
|
|a DG1
|b eng
|c DG1
|d DG1
|d YDXCP
|d OCLCQ
|d OCLCF
|d OCLCA
|d DEBBG
|d OCLCQ
|d GrThAP
|
| 020 |
|
|
|a 9780470923733
|q (electronic bk.)
|
| 020 |
|
|
|a 0470923733
|q (electronic bk.)
|
| 024 |
7 |
|
|a 10.1002/9780470923733
|2 doi
|
| 029 |
1 |
|
|a GBVCP
|b 790197766
|
| 029 |
1 |
|
|a NZ1
|b 15916440
|
| 029 |
1 |
|
|a DEBBG
|b BV043392636
|
| 035 |
|
|
|a (OCoLC)695549660
|
| 037 |
|
|
|a 10.1002/9780470923733
|b Wiley InterScience
|n http://www3.interscience.wiley.com
|
| 050 |
|
4 |
|a RM301.25
|b .R63 2011
|
| 082 |
0 |
4 |
|a 615/.19
|2 22
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a RNA interference :
|b application to drug discovery and challenges to pharmaceutical development /
|c edited by Paul H. Johnson.
|
| 264 |
|
1 |
|a Hoboken :
|b John Wiley & Sons,
|c [2011]
|
| 264 |
|
4 |
|c ©2011
|
| 300 |
|
|
|a xvi, 450 pages :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Frontmatter -- Color Plates -- Biology of RNA Interference. RNA Interference: What is it? / James A Birchler -- Nucleic Acids as Regulatory Molecules / Faqing Huang, C J Yu, Yanlin Guo -- Use of SiRNA Oligonucleotides to Study Gene Function / Kristin A Wiederholt, Adam N Harris -- Genome Scanning by RNA Interference / Roderick L Beijersbergen, Oliver C Steinbach -- Development of SiRNA for Therapeutic Applications. Discovery of New SiRNA Delivery Agents / Paul H Johnson, Diane Frank, Kunyuan Cui, Roger Adami, Harry Wang, Michael Houston, Steven C Quay -- SiRNA Delivery Vehicles / Aliasger K Salem, Mark A Behlke -- Interferon, Cytokine Induction, and other Potential Toxicities / Adam Judge, Marjorie Robbins, Ian Maclachlan -- Application of RNA Interference to Viral Diseases / Ralph A Tripp, Stephen Mark Tompkins -- Index.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 533 |
|
|
|a Electronic reproduction.
|b Hoboken, N.J. :
|c Wiley InterScience,
|d 2011.
|n Mode of access: World Wide Web.
|n System requirements: Web browser.
|n Title from title screen (viewed on Jan. 4, 2011).
|n Access may be restricted to users at subscribing institutions.
|
| 650 |
|
0 |
|a Drug development.
|
| 650 |
|
0 |
|a RNA editing.
|
| 650 |
|
7 |
|a Drug development.
|2 fast
|0 (OCoLC)fst00898670
|
| 650 |
|
7 |
|a RNA editing.
|2 fast
|0 (OCoLC)fst01086255
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Johnson, Paul H.
|
| 710 |
2 |
|
|a Wiley InterScience (Online service)
|
| 776 |
0 |
|
|z 0470923733
|
| 776 |
0 |
|
|z 9780470923733
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9780470923733
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
